Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aphria Inc    APH   CA03765K1049

APHRIA INC (APH)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/10/2018 07/11/2018 07/12/2018 07/13/2018 07/16/2018 Date
12.03 11.94 11.98 11.75 10.9 Last
3113470 2326895 1378222 1736654 3670466 Volume
+1.60% -0.75% +0.34% -1.92% -7.23% Change
Financials (CAD)
Sales 2018 36,2 M
EBIT 2018 -8,36 M
Net income 2018 32,2 M
Finance 2018 93,9 M
Yield 2018 -
Sales 2019 211 M
EBIT 2019 25,0 M
Net income 2019 41,6 M
Finance 2019 90,8 M
Yield 2019 -
P/E ratio 2018 55,41
P/E ratio 2019 48,66
EV / Sales2018 65,6x
EV / Sales2019 11,3x
Capitalization 2 470 M
More Financials
Company
Aphria, Inc. engages in the production and supply of medical marijuana.Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry.The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. ... 
Sector
Pharmaceuticals
Calendar
08/01 | 01:00pmEarnings Release
More about the company
Surperformance© ratings of Aphria Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APHRIA INC
06/21Canada sets October start for legal recreational marijuana sales
RE
02/02APHRIA : Pot company Aphria to sell stake in U.S. cannabis grower
RE
01/03Canadian pot stocks surge on new U.S. fund, California legalization
RE
01/02TSX notches record high as resource shares climb
RE
2017IIROC Trade Resumption - Aphria Inc.
NE
2017IIROC Trade Halt - Aphria Inc.
NE
2017Aphria bets C$10 million on Canada's recreational marijuana market
RE
2017TSX ends lower as banks, mining stocks weigh
RE
2017APHRIA : Canada's Aphria to sell medical marijuana to Loblaws' pharmacy chain
RE
2017IIROC Trade Resumption - Aphria Inc.
NE
More news
Sector news : Alternative Medicine
07/16Startup Producing Cell-Grown Meat Raises New Funding
DJ
07/16J&J'S JANSSEN : Credence Trial of Invokana Being Stopped Early for Positive Effi..
DJ
07/16ASTRAZENECA : Swedish Business Appoints New CEO
DJ
07/16Indivior's shares soar 33 percent after U.S. court blocks sale of rival gener..
RE
07/16SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
More sector news : Alternative Medicine
News from SeekingAlpha
03/16Did Aurora Overpay For CanniMed? 
03/14Marijuana Stocks And Industry Drivers For 2018 
03/13Marijuana Sales To Start As Soon As August This Year 
03/12WEEKLY CANNABIS REPORT : Ontario And Canopy In The News 
03/08Could Aurora Lower Its Bid For CanniMed Too? 
Chart APHRIA INC
Duration : Period :
Aphria Inc Technical Analysis Chart | APH | CA03765K1049 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 23,9  CAD
Spread / Average Target 119%
EPS Revisions
Managers
NameTitle
Victor Neufeld Chairman, President & Chief Executive Officer
Cole Cacciavillani Chief Operating Officer & Director
Carl A. Merton Chief Financial Officer
John Cervini Director & VP-Infrastructure & Technology
Gary Leong Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC-55.26%1 906
BEIJING TONGRENTANG CO., LTD.12.53%7 438
CANOPY GROWTH CORP27.00%5 914
DONG-E-E-JIAO CO LTD--.--%5 230
HUTCHISON CHINA MEDITECH LIMITED-16.79%4 164
MEDRELEAF CORP39.17%2 326